MONOCLONAL-ANTIBODY 138H11 AGAINST GAMMA-GLUTAMYL-TRANSFERASE PROVIDES A POSSIBLE TOOL FOR TARGETING CALICHEAMICIN TO RENAL-CELL CARCINOMAS(RCC)

Authors
SCHMIDT CS WRASIDLO W KAUFMANN O SCHERBERICH JE GAEDICKE G FISCHER P
Citation
Cs. Schmidt et al., MONOCLONAL-ANTIBODY 138H11 AGAINST GAMMA-GLUTAMYL-TRANSFERASE PROVIDES A POSSIBLE TOOL FOR TARGETING CALICHEAMICIN TO RENAL-CELL CARCINOMAS(RCC), Cancer gene therapy, 4(5), 1997, pp. 306-306
Citations number
NO
Categorie Soggetti
Oncology,"Biothechnology & Applied Migrobiology
Journal title
Cancer gene therapy → ACNP
ISSN journal
09291903
Volume
4
Issue
5
Year of publication
1997
Pages
306 - 306
Database
ISI
SICI code
0929-1903(1997)4:5<306:M1AGP>2.0.ZU;2-L